Global B-Cell Non-Hodgkin's Lymphoma Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Page: 102
Published Date: 09 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global B-Cell Non-Hodgkin's Lymphoma Drug market size was valued at USD 8119.4 million in 2023 and is forecast to a readjusted size of USD 12940 million by 2030 with a CAGR of 6.9% during review period.
Non-Hodgkin's lymphoma is a type of cancer that begins in your lymphatic system, which is part of the body's germ-fighting immune system. In non-Hodgkin's lymphoma, white blood cells called lymphocytes grow abnormally and can form growths (tumors) throughout the body.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the B-Cell Non-Hodgkin's Lymphoma Drug industry chain, the market status of Hospital (Oral, Injection), Retail Pharmacy (Oral, Injection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of B-Cell Non-Hodgkin's Lymphoma Drug.
Regionally, the report analyzes the B-Cell Non-Hodgkin's Lymphoma Drug markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global B-Cell Non-Hodgkin's Lymphoma Drug market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the B-Cell Non-Hodgkin's Lymphoma Drug market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the B-Cell Non-Hodgkin's Lymphoma Drug industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Oral, Injection).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the B-Cell Non-Hodgkin's Lymphoma Drug market.
Regional Analysis: The report involves examining the B-Cell Non-Hodgkin's Lymphoma Drug market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the B-Cell Non-Hodgkin's Lymphoma Drug market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to B-Cell Non-Hodgkin's Lymphoma Drug:
Company Analysis: Report covers individual B-Cell Non-Hodgkin's Lymphoma Drug players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards B-Cell Non-Hodgkin's Lymphoma Drug This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Retail Pharmacy).
Technology Analysis: Report covers specific technologies relevant to B-Cell Non-Hodgkin's Lymphoma Drug. It assesses the current state, advancements, and potential future developments in B-Cell Non-Hodgkin's Lymphoma Drug areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the B-Cell Non-Hodgkin's Lymphoma Drug market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
B-Cell Non-Hodgkin's Lymphoma Drug market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Oral
Injection
Market segment by Application
Hospital
Retail Pharmacy
Other
Market segment by players, this report covers
Roche
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Eisai
Acrotech Biopharma
Teva
Eagle Pharmaceuticals
MundiPharma
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe B-Cell Non-Hodgkin's Lymphoma Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of B-Cell Non-Hodgkin's Lymphoma Drug, with revenue, gross margin and global market share of B-Cell Non-Hodgkin's Lymphoma Drug from 2019 to 2024.
Chapter 3, the B-Cell Non-Hodgkin's Lymphoma Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and B-Cell Non-Hodgkin's Lymphoma Drug market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of B-Cell Non-Hodgkin's Lymphoma Drug.
Chapter 13, to describe B-Cell Non-Hodgkin's Lymphoma Drug research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of B-Cell Non-Hodgkin's Lymphoma Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of B-Cell Non-Hodgkin's Lymphoma Drug by Type
1.3.1 Overview: Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Type in 2023
1.3.3 Oral
1.3.4 Injection
1.4 Global B-Cell Non-Hodgkin's Lymphoma Drug Market by Application
1.4.1 Overview: Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Other
1.5 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size & Forecast
1.6 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast by Region
1.6.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region, (2019-2030)
1.6.3 North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2019-2030)
1.6.4 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2019-2030)
1.6.6 South America B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Prospect (2019-2030)
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.1.4 Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments and Future Plans
2.2 Gilead Sciences
2.2.1 Gilead Sciences Details
2.2.2 Gilead Sciences Major Business
2.2.3 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.2.4 Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Gilead Sciences Recent Developments and Future Plans
2.3 TG Therapeutics
2.3.1 TG Therapeutics Details
2.3.2 TG Therapeutics Major Business
2.3.3 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.3.4 TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 TG Therapeutics Recent Developments and Future Plans
2.4 Bayer
2.4.1 Bayer Details
2.4.2 Bayer Major Business
2.4.3 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.4.4 Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bayer Recent Developments and Future Plans
2.5 Secura Bio
2.5.1 Secura Bio Details
2.5.2 Secura Bio Major Business
2.5.3 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.5.4 Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Secura Bio Recent Developments and Future Plans
2.6 Epizyme
2.6.1 Epizyme Details
2.6.2 Epizyme Major Business
2.6.3 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.6.4 Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Epizyme Recent Developments and Future Plans
2.7 Eisai
2.7.1 Eisai Details
2.7.2 Eisai Major Business
2.7.3 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.7.4 Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Eisai Recent Developments and Future Plans
2.8 Acrotech Biopharma
2.8.1 Acrotech Biopharma Details
2.8.2 Acrotech Biopharma Major Business
2.8.3 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.8.4 Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Acrotech Biopharma Recent Developments and Future Plans
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.9.4 Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Teva Recent Developments and Future Plans
2.10 Eagle Pharmaceuticals
2.10.1 Eagle Pharmaceuticals Details
2.10.2 Eagle Pharmaceuticals Major Business
2.10.3 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.10.4 Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Eagle Pharmaceuticals Recent Developments and Future Plans
2.11 MundiPharma
2.11.1 MundiPharma Details
2.11.2 MundiPharma Major Business
2.11.3 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
2.11.4 MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 MundiPharma Recent Developments and Future Plans
3.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of B-Cell Non-Hodgkin's Lymphoma Drug by Company Revenue
3.2.2 Top 3 B-Cell Non-Hodgkin's Lymphoma Drug Players Market Share in 2023
3.2.3 Top 6 B-Cell Non-Hodgkin's Lymphoma Drug Players Market Share in 2023
3.3 B-Cell Non-Hodgkin's Lymphoma Drug Market: Overall Company Footprint Analysis
3.3.1 B-Cell Non-Hodgkin's Lymphoma Drug Market: Region Footprint
3.3.2 B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Type Footprint
3.3.3 B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value and Market Share by Type (2019-2024)
4.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast by Type (2025-2030)
5.1 Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Application (2019-2024)
5.2 Global B-Cell Non-Hodgkin's Lymphoma Drug Market Forecast by Application (2025-2030)
6.1 North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2030)
6.2 North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2030)
6.3 North America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country
6.3.1 North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2019-2030)
6.3.2 United States B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
6.3.3 Canada B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
6.3.4 Mexico B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
7.1 Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2030)
7.2 Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2030)
7.3 Europe B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country
7.3.1 Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2019-2030)
7.3.2 Germany B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
7.3.3 France B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
7.3.4 United Kingdom B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
7.3.5 Russia B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
7.3.6 Italy B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
8.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2030)
8.2 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2030)
8.3 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Region
8.3.1 Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2019-2030)
8.3.2 China B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
8.3.3 Japan B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
8.3.4 South Korea B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
8.3.5 India B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
8.3.7 Australia B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
9.1 South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2030)
9.2 South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2030)
9.3 South America B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country
9.3.1 South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2019-2030)
9.3.2 Brazil B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
9.3.3 Argentina B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
10.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2030)
10.2 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2030)
10.3 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Market Size by Country
10.3.1 Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2019-2030)
10.3.2 Turkey B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
10.3.4 UAE B-Cell Non-Hodgkin's Lymphoma Drug Market Size and Forecast (2019-2030)
11.1 B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
11.2 B-Cell Non-Hodgkin's Lymphoma Drug Market Restraints
11.3 B-Cell Non-Hodgkin's Lymphoma Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12.1 B-Cell Non-Hodgkin's Lymphoma Drug Industry Chain
12.2 B-Cell Non-Hodgkin's Lymphoma Drug Upstream Analysis
12.3 B-Cell Non-Hodgkin's Lymphoma Drug Midstream Analysis
12.4 B-Cell Non-Hodgkin's Lymphoma Drug Downstream Analysis
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 8. Roche B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Recent Developments and Future Plans
Table 10. Gilead Sciences Company Information, Head Office, and Major Competitors
Table 11. Gilead Sciences Major Business
Table 12. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 13. Gilead Sciences B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Gilead Sciences Recent Developments and Future Plans
Table 15. TG Therapeutics Company Information, Head Office, and Major Competitors
Table 16. TG Therapeutics Major Business
Table 17. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 18. TG Therapeutics B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. TG Therapeutics Recent Developments and Future Plans
Table 20. Bayer Company Information, Head Office, and Major Competitors
Table 21. Bayer Major Business
Table 22. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 23. Bayer B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Bayer Recent Developments and Future Plans
Table 25. Secura Bio Company Information, Head Office, and Major Competitors
Table 26. Secura Bio Major Business
Table 27. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 28. Secura Bio B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Secura Bio Recent Developments and Future Plans
Table 30. Epizyme Company Information, Head Office, and Major Competitors
Table 31. Epizyme Major Business
Table 32. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 33. Epizyme B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Epizyme Recent Developments and Future Plans
Table 35. Eisai Company Information, Head Office, and Major Competitors
Table 36. Eisai Major Business
Table 37. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 38. Eisai B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Eisai Recent Developments and Future Plans
Table 40. Acrotech Biopharma Company Information, Head Office, and Major Competitors
Table 41. Acrotech Biopharma Major Business
Table 42. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 43. Acrotech Biopharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Acrotech Biopharma Recent Developments and Future Plans
Table 45. Teva Company Information, Head Office, and Major Competitors
Table 46. Teva Major Business
Table 47. Teva B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 48. Teva B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Teva Recent Developments and Future Plans
Table 50. Eagle Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. Eagle Pharmaceuticals Major Business
Table 52. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 53. Eagle Pharmaceuticals B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Eagle Pharmaceuticals Recent Developments and Future Plans
Table 55. MundiPharma Company Information, Head Office, and Major Competitors
Table 56. MundiPharma Major Business
Table 57. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Product and Solutions
Table 58. MundiPharma B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. MundiPharma Recent Developments and Future Plans
Table 60. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue (USD Million) by Players (2019-2024)
Table 61. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Share by Players (2019-2024)
Table 62. Breakdown of B-Cell Non-Hodgkin's Lymphoma Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 63. Market Position of Players in B-Cell Non-Hodgkin's Lymphoma Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 64. Head Office of Key B-Cell Non-Hodgkin's Lymphoma Drug Players
Table 65. B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Type Footprint
Table 66. B-Cell Non-Hodgkin's Lymphoma Drug Market: Company Product Application Footprint
Table 67. B-Cell Non-Hodgkin's Lymphoma Drug New Market Entrants and Barriers to Market Entry
Table 68. B-Cell Non-Hodgkin's Lymphoma Drug Mergers, Acquisition, Agreements, and Collaborations
Table 69. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (USD Million) by Type (2019-2024)
Table 70. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Share by Type (2019-2024)
Table 71. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Forecast by Type (2025-2030)
Table 72. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2024)
Table 73. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Forecast by Application (2025-2030)
Table 74. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 75. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 76. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 77. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 78. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 79. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 80. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 81. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 82. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 83. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 84. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 85. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 86. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 87. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 88. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 89. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 90. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 91. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 92. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 93. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 94. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 95. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 96. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 97. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 98. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 99. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 100. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 101. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 102. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 103. Middle East & Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 104. B-Cell Non-Hodgkin's Lymphoma Drug Raw Material
Table 105. Key Suppliers of B-Cell Non-Hodgkin's Lymphoma Drug Raw Materials
List of Figures
Figure 1. B-Cell Non-Hodgkin's Lymphoma Drug Picture
Figure 2. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Type in 2023
Figure 4. Oral
Figure 5. Injection
Figure 6. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Application in 2023
Figure 8. Hospital Picture
Figure 9. Retail Pharmacy Picture
Figure 10. Other Picture
Figure 11. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Market B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 14. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Region (2019-2030)
Figure 15. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Region in 2023
Figure 16. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 17. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 18. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 19. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 20. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 21. Global B-Cell Non-Hodgkin's Lymphoma Drug Revenue Share by Players in 2023
Figure 22. B-Cell Non-Hodgkin's Lymphoma Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 23. Global Top 3 Players B-Cell Non-Hodgkin's Lymphoma Drug Market Share in 2023
Figure 24. Global Top 6 Players B-Cell Non-Hodgkin's Lymphoma Drug Market Share in 2023
Figure 25. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Share by Type (2019-2024)
Figure 26. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share Forecast by Type (2025-2030)
Figure 27. Global B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Share by Application (2019-2024)
Figure 28. Global B-Cell Non-Hodgkin's Lymphoma Drug Market Share Forecast by Application (2025-2030)
Figure 29. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Type (2019-2030)
Figure 30. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Application (2019-2030)
Figure 31. North America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Country (2019-2030)
Figure 32. United States B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 33. Canada B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 34. Mexico B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 35. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Type (2019-2030)
Figure 36. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Application (2019-2030)
Figure 37. Europe B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Country (2019-2030)
Figure 38. Germany B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 39. France B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 40. United Kingdom B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 41. Russia B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 42. Italy B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 43. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Type (2019-2030)
Figure 44. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Application (2019-2030)
Figure 45. Asia-Pacific B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Region (2019-2030)
Figure 46. China B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 47. Japan B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 48. South Korea B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 49. India B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 50. Southeast Asia B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 51. Australia B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 52. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Type (2019-2030)
Figure 53. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Application (2019-2030)
Figure 54. South America B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Country (2019-2030)
Figure 55. Brazil B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 56. Argentina B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 57. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Type (2019-2030)
Figure 58. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Application (2019-2030)
Figure 59. Middle East and Africa B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value Market Share by Country (2019-2030)
Figure 60. Turkey B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 61. Saudi Arabia B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 62. UAE B-Cell Non-Hodgkin's Lymphoma Drug Consumption Value (2019-2030) & (USD Million)
Figure 63. B-Cell Non-Hodgkin's Lymphoma Drug Market Drivers
Figure 64. B-Cell Non-Hodgkin's Lymphoma Drug Market Restraints
Figure 65. B-Cell Non-Hodgkin's Lymphoma Drug Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of B-Cell Non-Hodgkin's Lymphoma Drug in 2023
Figure 68. Manufacturing Process Analysis of B-Cell Non-Hodgkin's Lymphoma Drug
Figure 69. B-Cell Non-Hodgkin's Lymphoma Drug Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Roche Gilead Sciences TG Therapeutics Bayer Secura Bio Epizyme Eisai Acrotech Biopharma Teva Eagle Pharmaceuticals MundiPharma
Related Reports
09 Jan 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
